It was established that IL-6 is elevated in tissues of BPH and prostate carcinomas in men74 and intratumoral IL-1β levels significantly correlate with biochemical recurrence in prostate cancer patients75. The gene discussed is IL1B; the disease is benign prostatic hyperplasia.